# Immunome Inc.: Form 8-K, filed Mar 26, 2024

- Company: [Immunome Inc.](/companies/imnm.md) (CIK 1472012)
- Form: 8-K
- Filed: 2024-03-26
- Accepted by EDGAR: Mar 26, 2024, 08:05 ET
- Period: 2024-03-25
- Accession: 0001104659-24-038744
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1472012/000110465924038744/tm249326d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1472012/000110465924038744/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1472012/000110465924038744/tm249326d1_8k.htm

Filed Mar 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-038744. Last ingested by Listed: Oct 30, 2026, 12:06 ET. No prices; not investment advice.